GTx, Inc. to Participate in the Baird 2018 Global Healthcare Conference

GTx, Inc. to Participate in the Baird 2018 Global Healthcare Conference

News Releases

View printer-friendly version
<< Back
GTx, Inc. to Participate in the Baird 2018 Global Healthcare Conference

MEMPHIS, Tenn.--(BUSINESS WIRE)--Aug. 30, 2018-- GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, and other senior executive management team members will present a company overview at the Baird 2018 Global Healthcare Conference on Thursday, September 6, 2018 at 9:05 am ET in New York.

A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.

Source: GTx, Inc.

GTx, Inc.
Investors:
Argot Partners
Kimberly Minarovich or Sam Martin
212-600-1902
or
Media:
Red House Consulting
Denise Powell, 510-703-9491
denise@redhousecomms.com